Substituted isoindole-1,3-diones
AssigneeJanssen Pharmaceutica NV
InventorsGeorge Chiu, Peter J. Connolly, Jessica J. Liu, Steven A. Middleton, Virginia L. Pulito, Shengjian Li
Life of this patent
Estimating the term…
Abstract
The present invention relates to substituted isoindole-1,3-dione compounds of Formula (I) and pharmaceutically acceptable forms thereof, as α1a/α1d adrenoreceptor modulators for the treatment of benign prostatic hypertrophy and lower urinary tract symptoms. The present invention also relates to pharmaceutical compositions comprising said new compounds, new processes to prepare these new compounds and new uses as a medicine as well as methods of treatment.
Claims1
A compound and pharmaceutically acceptable salts thereof selected from the group consisting of:
Dependencies are inferred from the claim text.